Steroid-Sensitive Nephrotic Syndrome

Comprehensive Pediatric Nephrology

Volumn , Issue , 2008, Pages 239-256

  Hodson, Elisabeth M ^a   Alexander, Stephen I ^a   Graf, Nicole ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865161050     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04883-5.50021-0     Document Type: Chapter

References (210)

1. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978, 13(2):159-165.
2. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981, 98(4):561-564. The primary nephrotic syndrome in children.
3. Koskimies O, Vilska J, Rapola J, Hallman N Long-term outcome of primary nephrotic syndrome. Arch Dis Child 1982, 57(7):544-548.
4. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 2003, 41(3):550-557.
5. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997, 8(5):769-776.
6. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 2001, 16(12):1040-1044.
7. Schlesinger ER, Sultz HA, Mosher WE, Feldman JG The nephrotic syndrome. Its incidence and implications for the community. Am J Dis Child 1968, 116(6):623-632.
8. Srivastava T, Simon SD, Alon US High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol 1999, 13(1):13-18.
9. Fletcher JT, Hodson EM, Willis NS, Puckeridge S, Craig JC Population-based study of nephrotic syndrome: Incidence, demographics, clinical presentation and risk factors. Pediatr Nephrol 2004, 19:C96.
10. Sharples PM, Poulton J, White RH Steroid responsive nephrotic syndrome is more common in Asians. Arch Dis Child 1985, 60(11):1014-1017.
11. Feehally J, Kendell NP, Swift PG, Walls J High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child 1985, 60(11):1018-1020.
12. Elzouki AY, Amin F, Jaiswal OP Primary nephrotic syndrome in Arab children. Arch Dis Child 1984, 59(3):253-255.
13. Bhimma R, Coovadia HM, Adhikari M Nephrotic syndrome in South African children: changing perspectives over 20 years. Pediatr Nephrol 1997, 11(4):429-434.
14. Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J Is there really an increase in non-minimal change nephrotic syndrome in children? [Review]. Am J Kidney Dis 2003, 42(6):1107-1113.
15. Shalhoub RJ Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974, 2:556-560.
16. Routledge RC, Hann IM, Jones PH Hodgkin's disease complicated by the nephrotic syndrome. Cancer 1976, 38:1735-1740.
17. Yum MN, Edwards JL, Kleit S Glomerular lesions in Hodgkin disease. Arch Pathol 1975, 99:645-649.
18. Keng KL, Kuipers F Inoculation with measles virus in therapy of nephrotic syndrome. Ned Tijdschr Geneeskd 1951, 95:1806-1814.
19. Lander HB Effects of measles on nephrotic syndrome. Am J Dis Child 1949, 78:813-885.
20. Rosenblum AH, Lander HB, Fisher RM Measles in the nephrotic syndrome. J Pediatr 1949, 35:574-584.
21. Tejani A Morphological transition in minimal change nephrotic syndrome. Nephron 1985, 39(3):157-159.
22. Cambon-Thomsen A, Bouissou F, Abbal M, Duprat MP, Barthe P, et al. HLA and Bf in idiopathic nephrotic syndrome in children: differences between corticosensitive and corticoresistant forms. Pathol Biol (Paris) 1986, 34:725-730.
23. Kobayashi T, Ogawa A, Takahashi K, Uchiyama M HLA-DQB1 allele associates with idiopathic nephrotic syndrome in Japanese children. Acta Paediatr Jpn 1995, 37:293-296.
24. Lagueruela CC, Buettner TL, Cole BR, Kissane JM, Robson AM HLA extended haplotypes in steroid-sensitive nephrotic syndrome of childhood. Kidney Int 1990, 38:145-150.
25. Noss G, Bachmann HJ, Olbing H Association of minimal change nephrotic syndrome (MCNS) with HLA-B8 and B1 3. Clin Nephrol 1981, 15:172-174.
26. Brenchley PE Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant 2003, 18(suppl 6):vi21-vi25.
27. Eddy AA, Schnaper HW The nephrotic syndrome: from the simple to the complex. Semin Nephrol 1998, 18:304-316.
28. Schnaper HW, Aune TM Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J Clin Invest 1985, 76:341-349.
29. Matsumoto K, Kanmatsuse K Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome. Clin Nephrol 2001, 55:269-274.
30. Webb NJ, Watson CJ, Roberts IS, Bottomley MJ, Jones CA, et al. Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int 1999, 55:1063-1071.
31. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006, 17:724-735.
32. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716.
33. Schnaper HW, Aune TM Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome. J Clin Invest 1987, 79:257-264.
34. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996, 334:878-883.
35. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994, 330:7-14.
36. Garin EH, Laflam PF, Muffly K Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp Nephrol 2006, 102:e105-e112.
37. Abbas AK, Murphy KM, Sher A Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
38. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1996, 136:2348-2357.
39. Street NE, Mosmann TR Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991, 5:171-177.
40. Sad S, Marcotte R, Mosmann TR Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995, 2:271-279.
41. Cambon-Thomsen A, Bouissou F, Abbal M, Duprat MP, Barthe P, et al. HLA and Bf in idiopathic nephrotic syndrome in children: differences between corticosensitive and corticoresistant forms. PatholBiol (Paris) 1986, 34:725-730.
42. Fehervari Z, Sakaguchi S Development and function of CD25+CD4+ regulatory T cells. Curr Opin Immunol 2004, 16:203-238.
43. Hori S, Nomura T, Sakaguchi S Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
44. Iwakura Y, Ishigame H The IL-23/IL-17 axis in inflammation. J Clin Invest 2006, 116:1218-1222.
45. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
46. Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, et al. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006, 21:603-610.
47. Matsumoto K, Kanmatsuse K Increased urinary excretion of interleukin-17 in nephrotic patients. Nephron 2002, 91:243-249.
48. Bakr A, Rageh I, El Azouny M, Deyab S, Lotfy H Serum neopterin levels in children with primary nephrotic syndrome. Acta Paediatr 2006, 95:854-856.
49. Mansour H, Cheval L, Elalouf JM, Aude JC, Alyanakian MA, et al. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int 2005, 67:2168-2177.
50. Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, et al. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Nephrol Dial Transplant 2005, 20:539-544.
51. Strehlau J, Schachter AD, Pavlakis M, Singh A, Tejani A, Strom TB Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney Int 2002, 61:90-95.
52. Schachter AD The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity. Pediatr Transplant 2004, 8:344-348.
53. Aviles DH, Matti V, Manning J, Ochoa AC, Zea AH Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int 2004, 66:60-67.
54. Valanciute A, le Gouvello S, Solhonne B, Pawlak A, Grimbert P, et al. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J Immunol 2004, 172:688-698.
55. Ruf RG, Fuchshuber A, Karle SM, Lemainque A, Huck K, et al. Identification of the first gene locus (SSNS1) for steroid-sensitive nephrotic syndrome on chromosome 2p. J Am Soc Nephrol 2003, 14:1897-1900.
56. Murphy WM, Jukkola AF, Roy S Nephrotic syndrome with mesangial-cell proliferation in children-a distinct entity?. Am J Clin Pathol 1979, 72(1):42-47.
57. Waldherr R, Gubler MC, Levy M, Broyer M, Habib R The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol 1978, 10(5):171-179.
58. Zeis PM, Kavazarakis E, Nakopoulou L, Moustaki M, Messaritaki A, et al. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children. Pediatr Int 2001, 43(3):287-292.
59. Tejani A, Phadke K, Nicastri A, Adamson O, Chen CK, et al. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions. Nephron 1985, 41(2):170-173.
60. Kopolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R IgM nephropathy: morphological study related to clinical findings. Am J Nephrol 1987, 7(4):275-280.
61. Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, et al. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. Histopathology 1984, 8(3):435-446.
62. Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits.". Pediatr Nephrol 1988, 2(4):402-408.
63. Al Eisa A, Carter JE, Lirenman DS, Magil AB Childhood IgM nephropathy: comparison with minimal change disease. Nephron 1996, 72(1):37-43.
64. Myllymaki J, Saha H, Mustonen J, Helin H, Pasternack A IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 2003, 41(2):343-350.
65. Haas M, Yousefzadeh N Glomerular tip lesion in minimal change nephropathy: a study of autopsies before 1950. Am J Kidney Dis 2002, 39(6):1168-1175.
66. Howie AJ Pathology of minimal change nephropathy and segmental sclerosing glomerular disorders [Review]. Nephrol Dial Transplant 2003, 18(suppl 6):vi33-vi38.
67. Ostalska-Nowicka D, Zachwieja J, Maciejewski J, Wozniak A, Salwa-Urawska W The prognostic value of glomerular immaturity in the nephrotic syndrome in children. Pediatr Nephrol 2004, 19:633-637.
68. Ichikawa I, Fogo A Focal segmental glomerulosclerosis [Review]. Pediatr Nephrol 1996, 10(3):374-391.
69. Schnaper HW Idiopathic focal segmental glomerulosclerosis [Review]. Semin Nephrol 2003, 23(2):183-193.
70. McAdams AJ, Valentini RP, Welch TR The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change. Medicine 1997, 76(1):42-52.
71. D'Agati V Pathologic classification of focal segmental glomerulosclerosis [Review]. Semin Nephrol 2003, 23(2):117-134.
72. Habib R, Kleinknecht C The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases [Review]. Pathology Annual 1971, 6:417-474.
73. Meadow SR, Sarsfield JK Steroid-responsive and nephrotic syndrome and allergy: clinical studies. Arch Dis Child 1981, 56(7):509-516.
74. Arneil GC 164 children with nephrosis. Lancet 1961, 2:1103-1110.
75. Alwadhi RK, Mathew JL, Rath B Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health 2004, 40(1-2):28-32.
76. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ Nephrotic syndrome: from toddlers to twenties. Lancet 1989, 1(8632):255-259.
77. Takeda A, Takimoto H, Mizusawa Y, Simoda M Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2001, 16(11):888-893.
78. Yap HK, Han EJ, Heng CK, Gong WK Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2001, 16(12):1049-1052.
79. Constantinescu AR, Shah HB, Foote EF, Weiss LS Predicting first-year relapses in children with nephrotic syndrome. Pediatrics 2000, 105(3 Pt 1):492-495.
80. Lahdenkari AT, Suvanto M, Kajantie E, Koskimies O, Kestilä M, Jalanko H Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved?. Pediatr Nephrol 2005, 20:1073-1080.
81. Rüth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005, 147(2):202-207.
82. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 1985, 1(8425):368-370.
83. Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, et al. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 1987, 9(2):108-114.
84. Webb NJ, Lewis MA, Iqbal J, Smart PJ, Lendon M, Postlethwaite RJ Childhood steroid-sensitive nephrotic syndrome: does the histology matter?. Am J Kidney Dis 1996, 27(4):484-488.
85. Cattran DC, Rao P Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998, 32(1):72-79.
86. Abrantes MM, Cardosa LSB, Lima EM, Silva JMP, Diniz JS, et al. Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis. Pediatr Nephrol 2006, 21:482-489.
87. Ahmad H, Tejani A Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 2000, 84(4):342-346.
88. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children. Pediatrics 1984, 73(4):497-501.
89. Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 2004, 19:744-748.
90. Broyer M, Meyrier A, Niaudet P, Habib R Minimal changes and focal and segmental glomerular sclerosis. Oxford textbook of clinical nephrology 1992, Oxford University Press, Oxford. J.S. Cameron, A.M. Davison, J.P. Grunfeld, D. Kerr, E. Ritz (Eds.).
91. Gulati S, Sural S, Sharma RK, Gupta A, Gupta RK Spectrum of adolescent-onset nephrotic syndrome in Indian children. Pediatr Nephrol 2001, 16(12):1045-1048.
92. Gulati S, Sharma AP, Sharma RK, Gupta A, Gupta RK Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?. Pediatr Nephrol 2002, 17(6):404-408.
93. Baqi N, Singh A, Balachandra S, Ahmad H, Nicastri A, et al. The paucity of minimal change disease in adolescents with primary nephrotic syndrome. Pediatr Nephrol 1998, 12(2):105-107.
94. Primack WA, Schulman SL, Kaplan BS An analysis of the approach to management of childhood nephrotic syndrome by pediatric nephrologists. Am J Kidney Dis 1994, 23(4):524-527.
95. Siegel NJ, Gaudio KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment. Kidney Int 1981, 19:454-459.
96. Trachtman H, Carroll F, Phadke K, Khawar M, Nicastri A, et al. Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome. Am J Nephrol 1987, 7(1):13-17.
97. Sorof JM, Hawkins EP, Brewer ED, Boydstun II, Kale AS, Powell DR Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 1998, 12(9):764-768.
98. Stadermann MB, Lilien MR, van de Kar NC, Monnens LA, Schroder CH Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome?. Clin Nephrol 2003, 60(5):315-317.
99. White RH, Poole C Day care renal biopsy. Pediatr Nephrol 1996, 10(4):408-411.
100. Gipson DS, Chin H, Presler TP, Jennette C, Massengill S, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol 2006, 21:344-349.
101. Arneil GC Treatment of nephrosis with prednisolone. Lancet 1956, 1:409-411.
102. Arneil GC The nephrotic syndrome [Review]. Pediatr Clin North Am 1971, 18(2):547-559.
103. A report of Arbetsgemeinschaft für Pädiatrische Nephrologie. Lancet 1979, 1(8113):401-403. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome.
104. Hodson EM, Knight JF, Willis NS, Craig JC Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. Arch Dis Child 2000, 83(1):45-51.
105. Hodson EM, Knight JF, Willis NS, Craig JC Corticosteroid therapy for nephrotic syndrome in children. Update of Cochrane. Database SystRev 2004, CD001533,; PMID:15106158 [Review], Cochrane Database of Syst Rev: CD001533, 2005.
106. Ekka BK, Bagga A, Srivastava RN Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 1997, 11(5):597-599.
107. Choonara IA, Heney D, Meadow SR Low dose prednisolone in nephrotic syndrome. Arch Dis Child 1989, 64(4):610-611. 1.
108. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet 1988, 1(8582):380-383. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children.
109. Bagga A, Hari P, Srivastava RN Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 1999, 13(9):824-827.
110. Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, et al. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 1988, 112(1):122-126.
111. Norero C, Delucchi A, Lagos E, Rosati P Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children. Rev Med Chil 1996, 124(5):567-572.
112. Ehrich JH, Brodehl J Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children; Arbeitsgemeinschaft für Pädiatrische Nephrologie. Eur J Pediatr 1993, 152(4):357-361.
113. Ksiázek J, Wyszyńska T Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 1995, 84(8):889-893.
114. Jayantha UK Comparison of ISKDC regime with a 7 month regime in the first attack of nephrotic syndrome. Pediatr Nephrol 2004, 19:C81.
115. Pecoraro C, Caropreso MR, Malgieri G, Ferretti AVS, Raddi G, et al. Therapy of first episode of steroid responsive nephrotic syndrome: a randomised controlled trial. Pediatr Nephrol 2004, 19:C72.
116. Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, et al. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 2003, 41(6):1155-1162.
117. Sharma RK, Ahmed M, Gupta A, Gulati S, Sharma AP Comparison of abrupt withdrawal versus slow tapering regimens of prednisolone therapy in the management of first episode of steroid responsive childhood idiopathic nephrotic syndrome. J Am Soc Nephrol 2000, 11:97A.
118. Kleinknecht C, Broyer M, Parchoux B, Loriat C, Nivet H, Palcoux JB Comparison of short and long treatment at onset of steroid sensitive nephrosis. Int J Pediatr Nephrol 1982, 3:45.
119. Hodson EM, Craig JC, Willis NS Evidence-based management of steroid-sensitive nephrotic syndrome [Review]. Pediatr Nephrol 2005, 20:1523-1530.
120. Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, et al. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome; The West Japan Cooperative Study of Kidney Disease in Children. Kidney Int 2000, 58(3):1247-1252.
121. Lande MB, Leonard MB Variability among pediatric nephrologists in the initial therapy of nephrotic syndrome. Pediatr Nephrol 2000, 14(8-9):766-769.
122. Webb, NJ: 2006 (personal communication).
123. Brodehl J The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies [Review]. Eur J Pediatr 1991, 150(6):380-387.
124. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians [Review]. Arch Dis Child 1994, 70(2):151-157.
125. Wingen AM, Müller-Wiefel DE, Scharer K Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome. Clin Nephrol 1985, 23(1):35-40.
126. Narchi H Nephrotic syndrome relapse: need for a better evidence based definition. Arch Dis Child 2004, 89(4):395.
127. Jayantha UK Prolonged versus standard steroid therapy for children with a relapsing course of nephrotic syndrome. Pediatr Nephrol 2004, 19:C99.
128. Mattoo TK, Mahmoud MA Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Nephron 2000, 85(4):343-345.
129. Imbasciati E, Gusmano R, Edefonti A, Zucchelli P, Pozzi C, et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. British Medical Journal Clinical Research Ed 1985, 291(6505):1305-1308.
130. Elzouki AY, Jaiswal OP Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. Clin Pediatr 1988, 27(8):387-392.
131. Srivastava RN, Vasudev AS, Bagga A, Sunderam KR Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 1992, 6(3):247-250.
132. Ng JS, Wong W, Law RW, Hui J, Wong EN, Lam DS Ocular complications of paediatric patients with nephrotic syndrome. Clin Experiment Ophthalmol 2001, 29(4):239-243.
133. Brocklebank JT, Harcourt RB, Meadow SR Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Child 1982, 57(1):30-34.
134. Hall AS, Thorley G, Houtman PN The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol 2003, 18(12):1220-1223.
135. Broyer M, Guest G, Gagnadoux MF Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr 1992, 120(5):721-725.
136. Saha MT, Laippala P, Lenko HL Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone. Acta Paediatr 1998, 87(5):545-548.
137. Polito C, Oporto MR, Totino SF, La Manna A, Di Toro R Normal growth of nephrotic children during long-term alternate-day prednisone therapy. Acta Paediatr Scand 1986, 75(2):245-250.
138. Foote KD, Brocklebank JT, Meadow SR Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 1985, 2(8461):917-919.
139. Rees L, Greene SA, Adlard P, Jones J, Haycock GB, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 1988, 63(5):484-490.
140. Donatti TL, Koch VH, Fujimura MD, Okay Y Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol 2003, 18(8):789-795.
141. Emma F, Sesto A, Rizzoni G Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 2003, 18(8):783-788.
142. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol 1995, 9(3):278-281.
143. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?. Am J Kidney Dis 2003, 41(6):1163-1169.
144. Biyikli NK, Emre S, Sirin A, Bilge I Biochemical bone markers in nephrotic children. Pediatr Nephrol 2004, 19:869-873.
145. Bachrach LK Bare-bones fact-children are not small adults. N Eng J Med 2004, 351(9):924-996.
146. Freundlich M, Jofe M, Goodman WG, Salusky IB Bone histology in steroid-treated children with non-azotemic nephrotic syndrome. Pediatr Nephrol 2004, 19:400-407.
147. Munns CF, Cowell CT Prevention and treatment of osteoporosis in chronically ill children [Review]. J Musculoskel Neuronal Interact 2005, 5(3):262-272.
148. Schonau E The peak bone mass concept: is it still relevant? [Review]. Pediatr Nephrol 2004, 19:825-831.
149. Lettgen B, Jeken C, Reiners C Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 1994, 8(6):667-670.
150. Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy. Clin Pediatr 1995, 34(5):234-236.
151. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Eng J Med 2004, 351(9):868-875.
152. Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant 2005, 20:1598-1603.
153. Bak M, Serdaroglu E, Guclu R Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 2006, 21(3):350-354.
154. Coldbeck JH Experience with alkylating agents in the treatment of children with nephrotic syndrome. Med J Aust 1963, 2:987-989.
155. Grupe WE, Heymann W Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. American Journal of Diseases of Children 1966, 112(5):448-458.
156. Grupe WE, Makker SP, Ingelfinger JR Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Eng J Med 1976, 295(14):746-749.
157. Chiu J, McLaine PN, Drummond KN A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 1973, 82(4):607-613.
158. Alatas H, Wirya IG, Tambunan T, Himawan S Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report). J Med Asso Thai 1978, 61(suppl):222-228. 1.
159. Barratt TM, Soothill JF Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 1970, 2(7671):479-482.
160. Report of the International Study of Kidney Disease in Children. Lancet 1974, 2(7878):423-447. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome.
161. Durkan A, Hodson EM, Willis NS, Craig JC Non-corticosteroid treatment for nephrotic syndrome in children. Update of Cochrane Database. Syst Rev 2001, CD002290,; PMID: 116871550 [Review], Cochrane Database of Syst Rev: CD002290, 2005.
162. Durkan AM, Hodson EM, Willis NS, Craig JC Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 2001, 59(5):1919-1927.
163. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Eng J Med 1982, 306(8):444-451. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
164. Ueda N, Kuno K, Ito S Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990, 65(10):1147-1150.
165. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Arch Dis Child 1987, 62(11):1102-1106. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
166. Latta K, von Schnakenburg C, Ehrich JH A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001, 16(3):271-282.
167. Vester U, Kranz B, Zimmermann S, Hoyer PF Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol 2003, 18(7):644-661.
168. Prasad N, Gulati S, Sharma RK, Singh U, Ahmed M Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 2004, 19:494-498.
169. Gulati S, Pokhariyal S, Sharma RK, Elhence R, Kher V, et al. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 2001, 16(10):2013-2017.
170. Miller DG Alkylating agents and human spermatogenesis. JAMA 1971, 217(12):1662-1665.
171. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993, 8(12):1326-1332.
172. Niaudet P Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 1992, 6(1):1-3.
173. Hulton SA, Neuhaus TJ, Dillon MJ, Barratt TM Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 1994, 8(4):401-403.
174. Niaudet P, Broyer M, Habib R Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 1991, 35(suppl):S31-S36. 1.
175. Tirelli AS, Paterlini G, Ghio L, Edefonti A, Assael BM, et al. Renal effects of cyclosporin A in children treated for idiopathic nephrotic syndrome. Acta Paediatr 1993, 82(5):463-468.
176. D'Agati VD Morphologic features of cyclosporin nephrotoxicity [Review]. Contrib Nephrol 1995, 114:84-110.
177. Mihatsch MJ, Thiel G, Ryffel B Morphologic diagnosis of cyclo-sporine nephrotoxicity [Review]. Semin Diagn Pathol 1988, 5(1):104-121.
178. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002, 61(5):1801-1805.
179. Inoue Y, Iijima K, Nakamura H, Yoshikawa N Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 1999, 13(1):33-38.
180. Niaudet P, Habib R, Tete MJ, Hinglais N, Broyer M Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1987, 1(4):566-573.
181. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 2001, 16(9):723-727.
182. El Husseini A, El Basuony F, Mahmoud I, Donia A, Hassan N, et al. Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis. Pediatr Nephrol 2004, 19:976-981.
183. Filler G How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?. Nephrol Dial Transplant 2005, 20:1032-1034.
184. Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 2005, 20:1359-1360.
185. Davin JC, Merkus MP Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? [Review]. Pediatr Nephrol 2005, 20:10-14.
186. Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S Treatment of nephrotic syndrome with levamisole. J Pediatr 1980, 96(3 Pt 1):490-493.
187. Dayal U, Dayal AK, Shastry JC, Raghupathy P Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children [erratum in Nephron 67(4): 507, 1994]. Nephron 1994, 66(4):408-412.
188. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood; British Association for Paediatric Nephrology. Lancet 1991, 337(8757):1555-1557.
189. Rashid HU, Ahmed S, Fatima N, Khanam A Levamisole in the treatment of steroid dependent or frequently relapsing nephrotic syndrome in children. Bangladesh Renal Journal 1996, 15(1):6-8.
190. Weiss R Randomized double-blind placebo controlled, multi-center trial of levamisole for children with frequently relapsing/ steroid dependent nephrotic syndrome. J Am Soc Nephrol 1993, 4:289.
191. Donia AF, Ammar HM, El Agroudy A, Moustafa F, Sobh MA Long-term results of two unconventional agents in steroid-dependent nephrotic children. Pediatr Nephrol 2005, 20:1420-1425.
192. Alsaran K, Grisaru S, Stephens D, Arbus G Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 2001, 56(4):289-294.
193. Palcoux JB, Niaudet P, Goumy P Side effects of levamisole in children with nephrosis. Pediatr Nephrol 1994, 8(2):263-264.
194. Barbano G, Ginevri F, Ghiggeri GM, Gusmano R Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 1999, 13(7):602-603.
195. Bagga A, Hari P, Moudgil A, Jordan SC Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 2003, 42(6):1114-1120.
196. Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, et al. Clinical trial of mycophenolate mofetil (MMF) for frequent relapsing nephrotic syndrome in children. Pediatr Nephrol 2004, 19:C18.
197. Mendizabal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J Mycophenolate mofetil in steroid/cyclosporine-dependent/ resistant nephrotic syndrome. Pediatr Nephrol 2005, 20:914-919.
198. Ulinski T, Dubourg L, Said MH, Parchoux B, Ranchin B, Cochat P Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol 2005, 20:482-485.
199. Abramowicz M, Barnett HL, Edelmann CM, Greifer I, Kobayashi O, et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the International Study of Kidney Disease in Children. Lancet 1970, 1(7654):959-961.
200. Barratt TM, Cameron JS, Chantler C, Counahan R, Ogg CS, Soothill JF Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. Arch Dis Child 1977, 52(6):462-463.
201. Hiraoka M, Tsukahara H, Hori C, Ohshima Y, Momoi T, et al. Efficacy of long-term azathioprine for relapsing nephrotic syndrome. Pediatr Nephrol 2000, 14(8-9):776-778.
202. Honda M Nephrotic syndrome and mizoribine in children [Review]. Pediatr Int 2002, 44(2):210-216.
203. Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, et al. A multi-center trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 2000, 58(1):317-324.
204. Rowe PC, McLean RH, Ruley EJ, Salcedo JR, Baumgardner RA, et al. Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trial. Pediatr Nephrol 1990, 4(1):32-35.
205. Trompeter RS, Thomson PD, Barratt TM, Soothill JF Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood. Arch Dis Child 1978, 53(5):430-432.
206. Sinha MD, MacLeod R, Rigby E, Clark AG Treatment of severe steroid dependent nephrotic syndrome (SDNS) in paediatrics with tacrolimus therapy. Pediatr Nephrol 2004, 19:C72.
207. Kausman JY, Yin L, Jones CL, Johnstone L, Powell HR Vincristine treatment in steroid-dependent nephrotic syndrome. Pediatr Nephrol 2005, 20:1416-1419.
208. Jayantha UK Captopril therapy in children with steroid dependent nephrotic syndrome and their long term follow up. Pediatr Nephrol 2004, 19:C98.
209. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 2000, 105(6):1242-1249.
210. Consensus statement on management of steroid sensitive nephrotic syndrome [Review]. Indian Pediatr 2001, 38(9):975-986. Indian Pediatric Nephrology Group IAoP.